Dedicated to finding a real cure, as possible regarding Multiple Sclerosis & Chronic Cerebrospinal Venous Insufficiency (CCSVI)

Submitted by savcash on Thu, 03/10/2011 - 17:41.

Multiple Sclerosis affetcs millions. There now is something that has helped thousands. BUT, the  MS society and some neurologists are

downplaying the importance of this life saving news. Could it be that it will affect their bottom line?

Please see http://www.reallynews.com/  for many videos, stats and reports on the CCSVI

>>>copy>>

Dedicated to finding a real cure, to providing as many resources as possible regarding world news and also a variety of sites for Multiple Sclerosis and Chronic Cerebrospinal Venous Insufficiency (CCSVI).  This site attempts to present many different views with as much objectivity as possible.  (Note: This is not a "Helping  you to live comfortably with your MS"  zone.  Dedicated to helping find an actual cure for MS.)   READ World CCSVI PUBLICATIONS HERE (Switzerland) & Significance of Localized Vasoconstrictions in MS (1950) & SEE CCSVI Social Group Locator [//]

 

This is a new friend, who shows before and after the CCSVI procedure, on how Multiple Sclerosis had affected her life, and now, since this 'LIBERATION'.

http://www.youtube.com/watch?v=38LefQwKlnQ&feature=related   if you will watch that, you will see the awesome results.

Alot of before and after videos on youtube, google CCSVI

Be well, Betty

( categories: )

putting an update

 

http://www.youtube.com/watch?v=eu3Ij64f2Tg 

thankyou Dr Zamboni :)  reading the comments below, you will understand more

http://www.bbc.co.uk/dna/mbpointsofview/NF1951566?thread=8108628

TRUST IS NOT ONLY VIOLATED BY FALSEHOOD,IT MAY BE OUTRAGED SILENCE.  Betty

The problem is, America is NOT a Democracy - it is a Republic! As our Founding Fathers established, can we keep it?

Dizzying Excitement, Desperate Hope for those with MS

 

 

From Medscape Medical News

Endovascular Treatment of Cerebrospinal Venous Insufficiency Safe, May Provide Benefit in MS

Susan Jeffrey

December 3, 2009 — New data from a pilot open-label study suggest that endovascular treatment of strictures in extracranial cerebrospinal veins is safe in patients with multiple sclerosis (MS) and may provide some neurological benefit for these patients, researchers conclude.

The controversial approach, which has recently been making headlines in consumer media outlets, proposes that narrowing in the veins draining the brain, called chronic cerebrospinal venous insufficiency (CCVI), may be an early step in the disease process causing MS, and further, this narrowing may respond to simple angioplasty.

Left: location of venous stenosis with relative rate found in CCVI associated with multiple sclerosis. Right: the minimally invasive technique of balloon angioplasty eliminates the stricture in the cerebral venous system.

Lead author Paolo Zamboni, MD, director of the Vascular Diseases Center at the University of Ferrara, Italy, emphasized that the current report should be viewed as an interesting finding that urgently requires replication by other groups.

"What we know is that MS is very complex and multifactorial," Dr. Zamboni told Medscape Neurology. "We have identified an unknown factor and possible treatment for this factor."

The study is published as an online article in the December issue of the Journal of Vascular Surgery.

CCVI and MS

In a previous study published online in December 2008, Dr. Zamboni and colleagues assessed venous outflow routes in 65 patients with clinically definite MS (CDMS) and 235 control patients using a combined transcranial and extracranial color Doppler high-resolution examination. They reported that CDMS and venous outflow abnormalities were "dramatically" associated, with an odds ratio of 43 (95% confidence interval, 29 - 65; P < .0001).

Venography showed the presence of multiple severe extracranial stenoses affecting the principal venous segments in the patients with MS but not the control patients. "This provides a picture of chronic cerebrospinal venous insufficiency with 4 different patterns of distribution of stenosis and substitute circle," the authors write. "Moreover, relapsing-remitting and secondary progressive courses were associated with CCVI patterns significantly different from those of primary progressive (P < .0001)" (Zamboni P, et al. J Neurol Neurosurg Psychiatry 2009;80:392-399).

In an editorial accompanying that publication, Claude Franceschi, MD, from Saint Joseph and Pitié-Salpétrière Hospitals in Paris wrote that, "in light of the association between such a previously overlooked vascular picture and MS, a further stimulating research field is opened by this article. This should be addressed in understanding the contribution of venous drainage to the different aspects of inflammation, autoimmunity and neurodegeneration characterising the intriguing puzzle of MS" (Franceschi C. J Neurol Neurosurg Psychiatry 2009;80:358).

Dr. Zamboni stressed that this association between venous stenoses in main extracranial veins and MS is not contradictory to what is already known about the disease. "What I've found is a previously unknown factor, widely diffuse in my MS population, which could trigger or facilitate both immune reaction and inflammation," he told Medscape Neurology. "If you have elevated pressure and difficulty of drainage in the brain, you have the possibility of extravasation of blood components crossing the blood–brain barrier, and this could trigger inflammation and also immune reaction."

Restenosis a Problem

In the current report, the researchers describe the safety and early outcomes in these same patients after endovascular treatment of stenoses in the internal jugular vein and the azygous vein.

Of the 65 patients, 35 had relapsing-remitting disease, 20 had secondary-progressive disease, and 10 had primary progressive MS. All underwent percutaneous transluminal angioplasty to address strictures in these veins. All procedures were done as day surgery under local anesthesia, and no operative or postoperative complications were seen, including vessel rupture, thrombosis, or adverse effects from contrast.

Postoperative headache was reported in 6 patients, which resolved spontaneously, and minor hemorrhages with hematoma occurred at vascular access sites "occasionally," the authors report.

After the procedure, venous pressure was significantly lower in the internal jugular and azygous veins (P < .001). Stenoses in these venous pathways "were never found to be isolated," the researchers note, but always combined in the internal jugular, azygous veins, or lumbar system in 4 main patterns of distribution.

At a mean follow-up of 18 months, the risk for restenosis after intervention was higher in the internal jugular vein, Dr. Zamboni noted, with a patency rate of 53% compared with 96% in azygous veins (95% confidence interval, 3.5 - 72.5; P < .0001).

Patency at follow-up depended on the type of obstruction faced, including membranous obstructions, twisting, and hypoplasia. A stent was placed in 1 patient to resolve a twisted vein, but a second case not treated with a stent retwisted, the authors note.

Using the patients as their own control, the researchers found improvement with treatment on some clinical outcome measures after the intervention, particularly for the relapsing-remitting patients. In this group, 27% were relapse-free before surgery and 50% were so after treatment (P < .001). Gadolinium-enhancing lesions on magnetic resonance imaging (MRI) fell from 50% to 12% on a blinded assessment (P < .001).

Significant improvement over the preoperative assessment was seen at 1 year on the Multiple Sclerosis Functional Composite again for relapsing-remitting patients (P < .008), but not among those with a secondary or primary progressive course.

Physical quality-of-life measures also improved significantly in relapsing-remitting MS patients and in primary-progressive patients, with a positive trend among those with secondary progressive disease. Mental quality of life also was significantly improved for the relapsing-remitting and primary progressive groups, but not for those with secondary progressive MS.

The authors conclude that although improved endovascular techniques are needed to approach the internal jugular vein, "the results of this pilot study warrant a subsequent randomized control study."

It is possible that the addition of stents to this endovascular approach that he calls the "liberation procedure" may improve outcomes, Dr. Zamboni noted. "However, the results are really interesting, if you think that all treated patients were already under the best treatment for MS and had adjunctive neurological benefits from the liberation procedure compared to the previous 2 years."

SNIP--- BALANCE OF ARTICLE AT www.medscape.com/viewarticle/713367

 [//]

PLEASE READ THIS OPEN LETTER TO PROFESSOR OF MEDICAL ETHICS AND LAW - UK, by Alison Fisheron March 12, 2011 at http://fb.me/UPPAmjIt 

My daughter-in-law is going for this procedure, and we are sure glad we found the news about it. Wish to share, Betty

 

The problem is, America is NOT a Democracy - it is a Republic! As our Founding Fathers established, can we keep it?